Specifically, OXSR1 has been previously reported to mediate the TGF-β signaling pathway in breast cancer, promoting epithelial-mesenchymal transition (EMT) and metastasis through the phosphorylation of Smad2/3 [19], EXOSC10 is a novel candidate factor that had not been identified before. Here, OXSR1 is linked to breast cancer.